01 — At a Glance
The Company That Burned Down Its House. Now Building Two.
- 52-Week High / Low₹314 / ₹197
- FY25 Revenue₹7,385 Cr
- FY25 PAT₹183 Cr
- FY25 EPS₹3.79
- Q3 FY26 PAT-₹77 Cr
- Book Value₹87.3
- Price to Book2.51x
- Dividend Yield0.00%
- Debt / Equity0.11x
- Return (1 Year)-9.47%
The Setup: Religare is not one company. It’s a broken mirror held together with governance tape and ambition. Care Health Insurance (₹9,200+ crore GWP, profitable) is thriving. Everything else is either bankrupt, bleeding, or praying for recovery. Q3 saw a ₹76 crore loss for the consolidated group. Board just approved a 1:1 demerger of financial services into Religare Finvest (RFL), expected listing by Q1 FY28. Shareholders get one share of RFL for every REL share held. This is not a bonus. This is triage.
02 — Introduction
Welcome to the Phoenix That Keeps Crashing Before It Flies
Religare Enterprises is what happens when a conglomerate gets drunk and decides to own everything. Health insurance. SME lending. Retail broking. Affordable housing. E-governance networks. The result? A company so complex that even insiders admit they can’t value it properly.
But here’s the thing: buried inside this charred wreckage is a legitimately good health insurance company called Care Health Insurance. Care pulled ₹9,223 crore in gross written premiums in FY25, growing at 21.5% YoY, capturing 19.5% market share among private retail health insurers. That’s not scrappy startup territory. That’s legitimate market leadership.
The rest of the portfolio? Not so much. Religare Finvest (RFL), the SME lending arm, had ₹2,500 crore stolen by its own promoters (the Singh brothers) back in 2017. That’s not ancient history—that’s last Tuesday in financial services. RFL was barred from new lending since January 2018 and has been in “recovery mode” for seven years. Religare Housing Finance is shrinking. Religare Broking’s ROCE is 0.82%. The holding company itself burns ₹11 crore per quarter just to exist.
On February 14, 2026—Valentine’s Day, because romance is dead—the Board approved a demerger. REL becomes a holding company owning just Care Health. RFL gets all the lending, broking, and housing businesses. Two separate listed entities by Q1 FY28. Shareholders get warrants worth ₹1,500 crore. The CFO is new. The CEO is interim. The MD of broking joined three weeks ago.
This is not restructuring. This is a controlled demolition.
Concall Note (Feb 16, 2026): “Building strong operating foundation rather than chasing short-term growth.” — Management. Translation: we’ve stopped pretending and started actual work.
03 — Business Model: What Does This Company Actually Own?
Insurance (92% of Revenue). Lending (8%). Chaos (100%).
Care Health Insurance (The Crown Jewel)
Religare owns 63.2% of Care Health. FY25 GWP: ₹9,223 crore. Retail channel growing 41% YoY. 21% market share in the SAHI (standalone health insurance) segment. Claims settlement ratio 97%. Premium deferred ₹1,400 crore due to new accounting rules — management says “timing issue, not economics,” which is technically true if you ignore economics.
Financial Services (The Zombie Units)
RFL (100% owned): ₹70 crore SME book left. ₹500 crore cash. Being prepped for restart “when leadership is hired and regulatory clarity exists.” Religare Housing (under RFL): ₹241 crore AUM, shrinking. RBL Broking: ₹317 crore margin trading book, bleeding clients at -11% YoY (though industry fell -12%, so technically winning).
**Revenue Mix FY25:** Health Insurance 92.5% (₹6,836 cr). Financial Services 7.5% (₹549 cr). This is not diversification. This is one thriving business carrying five hobbyists.
💬 If Care Health Insurance is so good, why is it still trapped inside this fractured conglomerate? The answer to that question is worth ₹2,000+ crore to shareholders. Literally. Post-demerger valuation arbitrage.
04 — Financials Overview
Q3 FY26: The Quarter Nobody Wanted to Remember
